Appeals court says J&J did not infringe stent patent, overturns $482 Mn decision

WASHINGTON — “A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.  The three-judge panel said a lower court misinterpreted the company’s patent and should not have ruled in favor of Bruce Saffran, a doctor from Princeton, N.J.”

Full Story on Washington Post here

Subscribe to get the latest news